Skip to main content
. 2001 Feb;69(2):1032–1043. doi: 10.1128/IAI.69.2.1032-1043.2001

TABLE 3.

Effects of drug treatment on host defense against C. albicans in HuCD4/Tg mice

Treatment Survival time (days after challenge [median]) C. albicans-specific IgG level in serum (OD at 1/20 [mean ± SD])
Vehicle 5.0 0.53 ± 0.18
Keliximab (1 mg/kg) 6.0 0.56 ± 0.20
Keliximab (100 mg/kg) 5.0 0.21 ± 0.14
Dexamethasone 1.0a 0.07 ± 0.02a
a

Statistically significant decrease in comparison to control (P < 0.05).